BARBARA AKOTO, M.D.
Adolescent Medicine (Internal Medicine) Physician in DAYTON, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
BARBARA AKOTO, M.D. filed 9,449 Medicare Part D claims in 2023 as a Adolescent Medicine (Internal Medicine) Physician in DAYTON, Ohio, prescribing 83% generic.
- 9K
- Part D claims, 2023
- 83%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
BARBARA AKOTO, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
9,449 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
BARBARA AKOTO, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about BARBARA AKOTO, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Ohio
How Adolescent Medicine (Internal Medicine) Physician compares to other specialties among Ohio providers
Adolescent Medicine (Internal Medicine) Physician share within Ohio
Adolescent Medicine (Internal Medicine) Physician is one of the more visible NUCC categories in Ohio
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Adolescent Medicine (Internal Medicine) Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Adolescent Medicine (Internal Medicine) Physician ABMS/AOA estimate
Est. board-certified rate (Adolescent Medicine (Internal Medicine) Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Adolescent Medicine (Internal Medicine) Physician US NPIs
Specialty board-certified rate — Adolescent Medicine (Internal Medicine) Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BARBARA AKOTO, M.D. appears in the CMS NPPES registry as a Adolescent Medicine (Internal Medicine) Physician provider holding M.D. credentials at 3300 PHILADELPHIA DR, DAYTON, OH, 45405, with a listed phone of (937) 274-1501. NPI 1992707913 was issued on 08/10/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AKOTO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 9,449 prescription claims written by this provider, covering 463 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 0.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Adolescent Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 377 enrolled providers across 46 states and an average of 3,242 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1992707913 |
|---|---|
| Specialty | Adolescent Medicine (Internal Medicine) Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 08/10/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BARBARA AKOTO, M.D.'s current license status, disciplinary history, and board certifications with the State Medical Board of Ohio in Ohio before relying on this page for a clinical or care decision.
How we sourced this profile
License & disciplinary context — Ohio OMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to BARBARA AKOTO, M.D.. To verify BARBARA AKOTO, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 9,449 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 18,687
- Total Day Supply
- 548,827
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $997K
- Generic Drug Cost
- $150K
- Opioid Claims
- 17 (0.2% rate)
- Antibiotic Claims
- 55
Patient Demographics
- Average Patient Age
- 70.4 years
- Avg HCC Risk Score
- 1.80
- Gender Split
- 77% female / 23% male
- Age Distribution
- <65: 98, 65-74: 209, 75-84: 113, 85+: 43
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What BARBARA AKOTO, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
630 claims
- Amlodipine Besylate
Amlodipine Besylate
519 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
323 claims
- Losartan Potassium
Losartan Potassium
298 claims
- Omeprazole
Omeprazole
278 claims
- Hydrochlorothiazide
Hydrochlorothiazide
254 claims
- Rosuvastatin Calcium 250
Rosuvastatin Calcium
250 claims
- Pantoprazole Sodium 244
Pantoprazole Sodium
244 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 630 |
| Amlodipine Besylate | 519 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 323 |
| Losartan Potassium | 298 |
| Omeprazole | 278 |
| Hydrochlorothiazide | 254 |
| Rosuvastatin Calcium | 250 |
| Pantoprazole Sodium | 244 |
| Gabapentin | 226 |
| Levothyroxine Sodium | 190 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Adolescent Medicine (Internal Medicine) Physician Overview
How BARBARA AKOTO, M.D. fits within the Adolescent Medicine (Internal Medicine) Physician landscape nationally.
BARBARA AKOTO, M.D.'s 9,449 claims are above the specialty average of 3,242.
Nearby Adolescent Medicine (Internal Medicine) Physician Providers in Ohio
Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as AKOTO.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Ohio
Frequently Asked Questions
What is BARBARA AKOTO, M.D.'s specialty? ▼
How much does BARBARA AKOTO, M.D. prescribe under Medicare Part D? ▼
Where is BARBARA AKOTO, M.D. located? ▼
What is BARBARA AKOTO, M.D.'s NPI number? ▼
Does BARBARA AKOTO, M.D. prescribe more brand-name or generic drugs? ▼
Does BARBARA AKOTO, M.D. prescribe opioids? ▼
How many Adolescent Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does BARBARA AKOTO, M.D. prescribe most often? ▼
Does BARBARA AKOTO, M.D. accept Medicare? ▼
How can I verify BARBARA AKOTO, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology